Daily Archives: 21, September 2017

EnBW orders further 117 rapid-charging stations from ABB

Major order from energy supplier EnBW for a further 117 charging stations in 2017 ZURICH, 21-Sep-2017 — /EuropaWire/ — ABB has received another major order from energy supplier EnBW for the expansion of the charging column network on German motorways. By … Read the full press release

Nova KBM completes the acquisition of Summit Leasing Slovenija (SLS)

MARIBOR, 21-Sep-2017 — /EuropaWire/ — Today (18. September 2017), Nova KBM (NKBM or the Bank) completed the acquisition of Summit Leasing Slovenija (SLS), one of the leading leasing companies in Slovenia. The transaction marks an important step towards realizing NKBM’s strategic goal of … Read the full press release

Bristol Medical School: The first trial to investigate The Lightning Process®(LP) published in the Archives of Disease in Childhood

BRISTOL, 21-Sep-2017 — /EuropaWire/ — The first trial to investigate The Lightning Process® (LP) is published today [Thursday 21 September] in the Archives of Disease in Childhood. In this trial, the effectiveness of LP in addition to specialist medical care was … Read the full press release

University of Bristol recipients of the European Research Council (ERC) Starting Grants

BRISTOL, 21-Sep-2017 — /EuropaWire/ — Five early-career researchers from the University of Bristol have been awarded over €7M in European Research Council (ERC) Starting Grants in recognition of their ‘excellent science’ and potentially ground-breaking research. Five early-career researchers from the University … Read the full press release

University of Bristol study shows that expressive faces on photos can cause identity confusions

Photos of the same person can look substantially different. For example, your passport photo may look quite different from your driving licence, or your face in holiday photos. BRISTOL, 21-Sep-2017 — /EuropaWire/ — In fact, these differences can mean you look … Read the full press release

Sanofi Genzyme, Alnylam Pharmaceuticals: APOLLO Phase 3 study of patisiran met its primary efficacy endpoint and all secondary endpoints

Investigational RNAi Therapeutic Patisiran Meets Primary and All Secondary Endpoints, with Highly Significant Reduction In Neuropathy Progression and Improvement in Quality of Life at 18 Months Relative to Placebo Alnylam Intends to File New Drug Application (NDA) in Late 2017 … Read the full press release

ABN AMRO launches new initiative for SMEs looking for a loan entirely online

AMSTERDAM, 21-Sep-2017 — /EuropaWire/ — Starting today, SMEs looking for a loan online can go to New10, an initiative of ABN AMRO. New10 lets them know within 15 minutes whether they qualify for a loan and under what terms and conditions. … Read the full press release

The Netherlands Authority for the Financial Markets (AFM) fined ABN AMRO Clearing Bank N.V. and ABN AMRO Bank N.V. for not complying with transaction-related reporting requirements

AMSTERDAMy, 21-Sep-2017 — /EuropaWire/ — The Netherlands Authority for the Financial Markets (AFM) has fined ABN AMRO Clearing Bank N.V. and ABN AMRO Bank N.V. for not completely complying with transaction-related reporting requirements. Under MiFID regulations, banks are required to submit … Read the full press release

Kudelski Group: Argentinian pay-TV operators CableVideo and Colsecor select technology and services from Conax

CableVideo deploys pay-TV and OTT advanced consumer offerings based on Conax multi-DRM content protection Colsecor’s operator cooperative deploys DVB content offering secured by Conax Contego, including modular Contego flexibility to enable advanced multi-device content offering in the future Strategic partner, … Read the full press release

Umeå University: membrane-derived vesicles (MVs) from Vibrio cholerae and Listeria monocytogenes transport pore-forming toxins (PFTs)

Umeå, Sweden, 21-Sep-2017 — /EuropaWire/ — Bacteria release membrane-derived vesicles (MVs), which are small particles that can transport virulence factors to neighbouring bacteria or to the cells of a mammalian host. This special MV-based system for delivering toxic proteins and nucleic … Read the full press release